Theralase Technologies (TLT) News Today C$0.23 0.00 (0.00%) As of 05/22/2026 03:33 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock TLT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Theralase Technologies (CVE:TLT) Stock Price Up 10.9% - Time to Buy?May 8, 2026 | marketbeat.comTheralase Technologies (CVE:TLT) Stock Price Down 5% - Should You Sell?May 5, 2026 | marketbeat.comTheralase Technologies (CVE:TLT) Trading Down 7.7% - Here's WhyApril 28, 2026 | marketbeat.comTheralase Technologies (CVE:TLT) Hits New 52-Week High - Should You Buy?April 24, 2026 | marketbeat.comTheralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical StudyApril 13, 2026 | theglobeandmail.comTheralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex VirusMarch 18, 2026 | theglobeandmail.comTheralase Technologies Inc.: Theralase(R) Closes $1.1 M Non-Brokered Private PlacementMarch 10, 2026 | finanznachrichten.deTheralase(R) Closes $1.1 M Non-Brokered Private PlacementMarch 10, 2026 | finance.yahoo.comNew bladder cancer drug may sharpen radiation's aimMarch 9, 2026 | msn.comLight-Activated Ruvidar and Interferon Demonstrate Enhanced EfficacyMarch 9, 2026 | theglobeandmail.comTheralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder CancerMarch 9, 2026 | finance.yahoo.comCorrecting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology CongressFebruary 21, 2026 | theglobeandmail.comTheralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology CongressFebruary 17, 2026 | finance.yahoo.comTheralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual MeetingFebruary 10, 2026 | finance.yahoo.comTheralase(R) Completes Enrollment in Bladder Cancer Clinical StudyFebruary 2, 2026 | finance.yahoo.comFerring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder CancerJanuary 12, 2026 | theglobeandmail.comTheralase and Ferring ink deal for new bladder cancer studyJanuary 12, 2026 | msn.comFerring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder CancerJanuary 12, 2026 | finance.yahoo.comAnalysts Expect Breakeven For Theralase Technologies Inc. (CVE:TLT) Before LongJanuary 2, 2026 | finance.yahoo.comTheralase raises C$1.3 million to advance bladder cancer trialDecember 23, 2025 | msn.comTheralase Launches Private Placement to Fund Cancer ResearchDecember 12, 2025 | tipranks.comTheralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyNovember 24, 2025 | finance.yahoo.comTheralase Technologies Secures Funding to Advance Cancer Treatment StudyNovember 24, 2025 | tipranks.comTheralase Reports Promising Cancer Study Results Amid Financial ChallengesNovember 18, 2025 | msn.comThe 5-Minute Investor Podcast, Ep. 37: Cancer-fighting stocksNovember 17, 2025 | msn.comA high-risk, high-reward bet on next-generation oncolytic and antiviral therapiesNovember 14, 2025 | msn.comTheralase Technologies Inc.: Theralase(R) Demonstrates Effectiveness of X-Ray-Activated DrugNovember 3, 2025 | finanznachrichten.deTheralase(R) Demonstrates Effectiveness of X-Ray-Activated DrugNovember 3, 2025 | finance.yahoo.comTheralase Reports Q2 2025 Financials and Clinical ProgressAugust 26, 2025 | tipranks.comTheralase Technologies Inc. (TLT.V) - Yahoo FinanceJuly 13, 2025 | finance.yahoo.comTheralase Technologies Extends Warrant Expiry to 2028June 30, 2025 | tipranks.comMultiple insider buying at Theralase Technologies (TLT)June 20, 2025 | theglobeandmail.comTheralase Completes $CAN 571,000 Private Placement to Advance Cancer ResearchJune 17, 2025 | tipranks.comTheralase Technologies Inc.: Theralase Completes Annual General and Special MeetingJune 12, 2025 | finanznachrichten.deTheralase Completes Annual General and Special MeetingJune 12, 2025 | finance.yahoo.comTheralase Annual General MeetingJune 5, 2025 | finance.yahoo.comTheralase Technologies Inc.: Theralase Annual General MeetingJune 5, 2025 | finanznachrichten.deCORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025May 30, 2025 | theglobeandmail.comTheralase(R) 1Q2025 Financial StatementsMay 30, 2025 | finance.yahoo.comTheralase to Present Groundbreaking Research at ASTRO 2025May 29, 2025 | seekingalpha.comTheralase Technologies Inc.: Theralase to Present Groundbreaking Research at ASTRO 2025May 29, 2025 | finanznachrichten.deTheralase Provides Corporate UpdateMay 20, 2025 | finance.yahoo.comTheralase Technologies Inc.May 12, 2025 | investing.comTheralase Technologies Inc.: Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological AssociationMay 5, 2025 | finanznachrichten.deTheralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological AssociationMay 5, 2025 | finance.yahoo.comTheralase uncovers new use-case for flagship drugApril 28, 2025 | msn.comTheralase Discovers New Mechanism of Action of Lead DrugApril 28, 2025 | markets.businessinsider.comTheralase Technologies Secures $CAN 419,124 in Private Placement to Boost Cancer and Virus ResearchApril 14, 2025 | tipranks.comRuvidar More Effective in the Treatment of Herpes than FDA-Approved TreatmentsApril 10, 2025 | markets.businessinsider.comRuvidar Demonstrates 7 Year Complete ResponseApril 7, 2025 | markets.businessinsider.com Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TLT Media Mentions By Week TLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLT News Sentiment▼1.000.45▲Average Medical News Sentiment TLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLT Articles This Week▼10▲TLT Articles Average Week Get the Latest News and Ratings for TLT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Theralase Technologies and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Quipt Home Medical News VentriPoint Diagnostics News MedX Health News Profound Medical News Organigram News Cardiol Therapeutics News BioSyent News HLS Therapeutics News Helix BioPharma News Zentek News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:TLT) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theralase Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theralase Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
